‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply




Broman Niklas, Feuth Thijs, Oksi Jarmo; COVIDSTORM study group

PublisherElsevier B.V.

2022

Clinical Microbiology and Infection

Clinical Microbiology and Infection

CLIN MICROBIOL INFEC

28

11

1520

1521

1469-0691

DOIhttps://doi.org/10.1016/j.cmi.2022.06.028(external)

https://doi.org/10.1016/j.cmi.2022.06.028(external)

https://research.utu.fi/converis/portal/detail/Publication/176385949(external)



Last updated on 2024-26-11 at 16:31